GlassScriptPhysician profile
Christopher P Kauffman
NPI 1578523809
$12,128.57
in general payments reported to CMS, 2019-2025
35 companies · $616 in 2025
The $616 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $2,078 · 2020: $1,213 · 2021: $2,327 · 2022: $4,649 · 2023: $769 · 2024: $476 · 2025: $616.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,513 · Travel and Lodging: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,513.01 |
| Travel and Lodging | $348.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Camber Spine Technologies LLC | $6,064.45 | 2019-2022 | |
| The Institute of Musculoskeletal Science and Education | $2,161.75 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $573.13 | 2019-2023 | Biomet Spinalpak / Orthopak |
| Intrinsic Therapeutics | $445.21 | 2021-2023 | Barricaid Acd (Annular Closure Device) |
| Alphatec Spine, INC | $348.00 | 2025 | Other - Miscellaneous |
| Medtronic USA, INC. | $250.29 | 2019 | |
| Theragen, INC. | $243.43 | 2024 | Actastim-S |
| Relievant Medsystems, INC. | $237.05 | 2021-2023 | Intracept |
| Corelink, LLC | $234.08 | 2019 | |
| Implanet America, INC. | $232.98 | 2024 | |
| Biedermann Motech, INC. | $169.61 | 2019 | |
| Nexxt Spine LLC | $148.12 | 2025 | Sa Alif & Pedicle Screws |
| Abbott Laboratories | $146.01 | 2019-2023 | Proclaim |
| Smith+Nephew, INC. | $138.13 | 2019-2021 | |
| Osteocentric Technologies, INC. | $95.37 | 2023 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Surgical Strategies, INC. | $90.00 | 2025 | |
| Choice Spine, LLC | $72.12 | 2021 | |
| Spinal Simplicity, LLC | $71.71 | 2021 | |
| Amgen INC. | $66.40 | 2020-2021 | |
| Arteriocyte Medical Systems, INC. | $47.29 | 2020-2021 | |
| Medtronic, INC. | $37.28 | 2022 | |
| Providence Medical Technology, INC. | $25.40 | 2019-2020 | |
| Trevena, INC. | $24.49 | 2021 | |
| Orthofix Medical, INC. | $22.76 | 2019-2021 | |
| Nevro Corp. | $21.85 | 2021 | |
| Pacira Therapeutics, INC. | $21.03 | 2020 | |
| Djo, LLC | $20.00 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $18.90 | 2021 | |
| Ethicon US, LLC | $16.13 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.97 | 2022 | |
| Depuy Synthes Sales INC. | $15.59 | 2025 | Tfn-Advance, Na |
| Orthogenrx INC. | $15.45 | 2019 | |
| Curonix LLC | $14.35 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Motive Health, INC. | $12.92 | 2019 | |
| Radius Health, INC. | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5,000.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Kauffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.